Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C806172-100 100 µl (1 mg/ml) $379 
LS-C806172-200 200 µl (1 mg/ml) $421 
TLR3 Antibody - 1:100 staining human brain carcinoma tissue by IHC-P. The sample was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The sample was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary.
TLR3 Antibody - Western blot analysis of extracts of Jurkat cells using TLR3 antibody. The lane on the left is treated with the antigen-specific peptide.
TLR3 Antibody - 1:100 staining human brain carcinoma tissue by IHC-P. The sample was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The sample was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary.
TLR3 Antibody - Western blot analysis of extracts of Jurkat cells using TLR3 antibody. The lane on the left is treated with the antigen-specific peptide.
1 of 2
2 of 2

Polyclonal Rabbit anti‑Human TLR3 Antibody (IHC, WB) LS‑C806172

Polyclonal Rabbit anti‑Human TLR3 Antibody (IHC, WB) LS‑C806172

Antibody:
TLR3 Rabbit anti-Human Polyclonal Antibody
Application:
IHC, WB, Peptide-ELISA
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Price
Catalog Number
$379
LS-C806172-100
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
TLR3 Rabbit anti-Human Polyclonal Antibody
Application:
IHC, WB, Peptide-ELISA
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified

Specifications

Description
TLR3 antibody LS-C806172 is an unconjugated rabbit polyclonal antibody to TLR3 from human. It is reactive with human, mouse and rat. Validated for IHC, Peptide-ELISA and WB.
Target
Human TLR3
Synonyms
TLR3 | CD283 | Toll-like receptor 3 | CD283 antigen | IIAE2
Host
Rabbit
Reactivity
Human, Mouse, Rat (tested or 100% immunogen sequence identity)
Clonality
IgG Polyclonal
Conjugations
Unconjugated
Purification
Peptide affinity chromatography.
Modifications
Unmodified
Immunogen
A synthesized peptide derived from human TLR3.
Specificity
TLR3 Antibody detects endogenous levels of total TLR3.
Applications
  • IHC (1:50 - 1:200)
  • Western blot (1:500 - 1:2000)
  • Peptide Enzyme-Linked Immunosorbent Assay (1:20000 - 1:40000)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Usage
For western blots: incubate membrane with diluted antibody overnight in 5% w/v milk , 1X TBS, 0.1% Tween-20 at 4°C with gentle shaking.
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Upon receipt, store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About TLR3
O15455 NM_003265 NP_003256.1

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 11/23/2024